Document is current
Any future updates will be listed below
-
Authors
Sansa, Aina https://orcid.org/0000-0003-4731-1722
Vásquez, Rosselin https://orcid.org/0000-0002-2483-9383
Valero, Cristina https://orcid.org/0000-0003-3397-2888
Vázquez, Cristina https://orcid.org/0000-0002-7231-0038
Holgado, Anna https://orcid.org/0000-0002-7478-8561
Gayà, Julia
Rubio, David
León, Xavier https://orcid.org/0000-0001-6286-630X
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (FIS PI24/01605)
Universitat Autònoma de Barcelona
- License Information
-
More Information
Article History
Received: 2 January 2025
Accepted: 27 February 2025
First Online: 5 May 2025
Declarations
:
: The authors declare that they have no conflicts of interest pertinent to this study. CV is listed as an inventor on IP owned by MSK on predictive models for immunotherapy response, unrelated to this study.
: The study has been performed in accordance with the ethical standards as stated in the 1964 Declaration of Helsinki and its later amendments. The study was approved by the Hospital de Sant Pau Institutional Review Board of the center (IIBSP-CCC-2023-88).
